- The cosmetic ingredient review: a status report.Clin Ther. 1981; 4: 2-6
- The cosmetic ingredient review—a safety evaluation program.J Am Acad Dermatol. 1984; 11: 1168-1174
- The cosmetic ingredient review.in: Estrin N.F. The cosmetic industry: scientific and regulatory foundations. Marcel Dekker, New York1984: 203-213
- The cosmetic ingredient review self-regulatory safety program.Derm Clin. 1991; 9: 105-122
- The cosmetic ingredient review.in: Estrin N.F. Akerson J.M. Cosmetic regulation in a competitive environment. Marcel Dekker, New York2000: 195-215
- Gottschalck T.E. McEwen Jr., G.N. 10th ed. International cosmetic ingredient dictionary and handbook. Vol 1-4. Cosmetic, Toiletry, and Fragrance Association, Washington (DC)2004
- J Environ Pathol Toxicol. 1980; 4: 147-170
National Institute of Occupational Safety and Health. Registry of Toxic Effects of Chemical Substances (RTECS). Available from: URL:http://www.cdc.gov/niosh/rtecs.html. Accessed March 25, 2002.
- J Am Coll Toxicol. 1998; 17: 1-241
Food and Drug Administration. Kava-containing dietary supplements may be associated with severe liver injury: consumer advisory. Available from: URL:http://www.cfsan.fda.gov/∼dms/addskava.html. Accessed March 25, 2002.
- IARC monographs on the evaluation of carcinogenic risks to humans: occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines.IARC. 1993; 57: 43-118
Helzlsouer K, Rollison D, Pinney S. Association between hair dye use and health outcomes: review of the literature published since 1992. Unpublished data submitted to CIR in 2003 prepared by Johns Hopkins University, Bloomberg School of Public Health. Baltimore (MA): 2003.
- Use of permanent hair dyes and bladder-cancer risk.Int J Cancer. 2001; 91: 575-579
- Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.Carcinogenesis. 2003; 24: 483-489
- Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut.Am J Epidemiol. 2004; 159: 148-154
- Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women.Am J Epidemiol. 2004; 159: 454-466
Support for the Cosmetic Ingredient Review (CIR) program, including members of the CIR Expert Panel (Drs Bergfeld, Belsito, and Marks) and director of the CIR (Dr Andersen), is received from the Cosmetics, Toiletry, and Fragrance Association.
Disclosure: Dr Marks coordinates a meeting, “contact dermatitis, state-of-the-art issues” through the Pennsylvania State University continuing education department that receives funding from the Rohm and Haas company, a manufacturer of chemicals used in cosmetics.